Prognostic value of folate-associated gene expression in stage II colon cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2025, v. 151, n. 2, p. 1, doi. 10.1007/s00432-025-06141-w
- By:
- Publication type:
- Article
Works matching AU Bexe-Lindskog, Elinor
Results: 16
1
2
γδ T cells in human colon adenocarcinomas comprise mainly Vδ1, Vδ2, and Vδ3 cells with distinct phenotype and function.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 9, p. 1, doi. 10.1007/s00262-024-03758-7
- By:
- Publication type:
- Article
3
Exhaustion in tumor-infiltrating Mucosal-Associated Invariant T (MAIT) cells from colon cancer patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3461, doi. 10.1007/s00262-021-02939-y
- By:
- Publication type:
- Article
4
Tumour differentiation grade is associated with TNM staging and the risk of node metastasis in colorectal cancer.
- Published in:
- Acta Oncologica, 2010, v. 49, n. 1, p. 57, doi. 10.3109/02841860903334411
- By:
- Publication type:
- Article
5
Impact of thymidine phosphorylase and CD163 expression on prognosis in stage II colorectal cancer.
- Published in:
- Clinical & Translational Oncology, 2022, v. 24, n. 9, p. 1818, doi. 10.1007/s12094-022-02839-2
- By:
- Publication type:
- Article
6
5-fluorouracil treatment of patient-derived scaffolds from colorectal cancer reveal clinically critical information.
- Published in:
- 2022
- By:
- Publication type:
- journal article
7
Regulatory T cells reduce endothelial neutral sphingomyelinase 2 to prevent T‐cell migration into tumors.
- Published in:
- European Journal of Immunology, 2021, v. 51, n. 9, p. 2317, doi. 10.1002/eji.202149208
- By:
- Publication type:
- Article
8
Genome-wide association study and meta-analysis in Northern European populations replicate multiple colorectal cancer risk loci.
- Published in:
- International Journal of Cancer, 2018, v. 142, n. 3, p. 540, doi. 10.1002/ijc.31076
- By:
- Publication type:
- Article
9
Immune Microenvironment in Sporadic Early-Onset versus Average-Onset Colorectal Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 5, p. 1457, doi. 10.3390/cancers15051457
- By:
- Publication type:
- Article
10
Increasing Dosage of Leucovorin Results in Pharmacokinetic and Gene Expression Differences When Administered as Two-Hour Infusion or Bolus Injection to Patients with Colon Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 1, p. 258, doi. 10.3390/cancers15010258
- By:
- Publication type:
- Article
11
Antigen Presenting Cells from Tumor and Colon of Colorectal Cancer Patients Are Distinct in Activation and Functional Status, but Comparably Responsive to Activated T Cells.
- Published in:
- Cancers, 2021, v. 13, n. 20, p. 5247, doi. 10.3390/cancers13205247
- By:
- Publication type:
- Article
12
Efficacy of hyperthermic intraperitoneal chemotherapy in colorectal cancer: A phase I and III open label randomized controlled registry-based clinical trial protocol.
- Published in:
- PLoS ONE, 2024, v. 19, n. 3, p. 1, doi. 10.1371/journal.pone.0294018
- By:
- Publication type:
- Article
13
TREM-1<sup>+</sup> Macrophages Define a Pathogenic Cell Subset in the Intestine of Crohn's Disease Patients.
- Published in:
- Journal of Crohn's & Colitis, 2021, v. 15, n. 8, p. 1346, doi. 10.1093/ecco-jcc/jjab022
- By:
- Publication type:
- Article
14
Patient‐derived scaffolds as a model of colorectal cancer.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 3, p. 867, doi. 10.1002/cam4.3668
- By:
- Publication type:
- Article
15
Intratumoral regulatory T cells from colon cancer patients comprise several activated effector populations.
- Published in:
- BMC Immunology, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s12865-021-00449-1
- By:
- Publication type:
- Article
16
MEFV and NLRP3 Inflammasome Expression Is Attributed to Immature Macrophages and Correlates with Serum Inflammatory Proteins in Crohn´s Disease Patients.
- Published in:
- Inflammation, 2022, v. 45, n. 4, p. 1631, doi. 10.1007/s10753-022-01647-8
- By:
- Publication type:
- Article